Tofacitinib can decrease anti-DNA antibody titers in inactive systemic lupus erythematosus complicated by rheumatoid arthritis.

Yamamoto, Motohisa; Yokoyama, Yoshihiro; Shimizu, Yui; Yajima, Hidetaka; Sakurai, Nodoka; Suzuki, Chisako; Naishiro, Yasuyoshi; Takahashi, Hiroki.

Afiliação

Yamamoto M; a Division of Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine , Sapporo , Hokkaido, Japan.
Yokoyama Y; a Division of Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine , Sapporo , Hokkaido, Japan.
Shimizu Y; a Division of Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine , Sapporo , Hokkaido, Japan.
Yajima H; a Division of Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine , Sapporo , Hokkaido, Japan.
Sakurai N; a Division of Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine , Sapporo , Hokkaido, Japan.
Suzuki C; b Department of Pediatrics , Sapporo Medical University School of Medicine , Sapporo , Hokkaido, Japan.
Naishiro Y; a Division of Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine , Sapporo , Hokkaido, Japan.
Takahashi H; a Division of Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine , Sapporo , Hokkaido, Japan.

Mod Rheumatol ; 26(4): 633-4, 2016 07.

Article em En | MEDLINE | ID: mdl-26140465